Praxis precision medicines to participate at the 2023 wedbush pacgrow healthcare conference

Boston, aug. 03, 2023 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate at the 2023 wedbush pacgrow healthcare conference on wednesday, august 9, 2023 at 9:30a.m. et on the panel david vs. goliath - how can orphan epilepsy development accelerate and broaden its reach? please contact your wedbush representative for details about how to participate.
PRAX Ratings Summary
PRAX Quant Ranking